Phase II Iressa Versus Vinorelbine (INVITE)

Clinical trial NCT00256711 · COMPLETED

Trial details

NCT number: NCT00256711
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small-Cell Lung Carcinoma

Start date: 2004-07-01
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.